Health Catalyst (NASDAQ:HCAT) Stock: Insider Benjamin Landry Sells 29,478 Shares

Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Benjamin Landry sold 29,478 shares of the firm’s stock in a transaction dated Thursday, November 12th. The shares were sold at an average price of $1.39, for a total value of $40,974.42. Following the sale, the general counsel owned 251,894 shares in the company, valued at $350,132.66. The trade was a 10.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Benjamin Landry also recently made the following trade(s):

• On Wednesday, November 11th, Benjamin Landry sold 70,000 shares of Health Catalyst stock. The stock was sold at an average price of $1.43, for a total value of $100,100.00.

Health Catalyst Trading Up 10.3%

Shares of HCAT traded up $0.14 during midday trading on Friday, reaching $1.50. The stock had a trading volume of 465,291 shares, compared to its average volume of 920,868. The company’s 50-day moving average is $1.69 and its 200 day moving average is $1.69. Health Catalyst, Inc. has a 12-month low of $0.96 and a 12-month high of $3.02. The company has a market capitalization of $114.22 million, a price-to-earnings ratio of -0.53 and a beta of 1.52.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. The firm had revenue of $56.28 million for the quarter, compared to analyst estimates of $55.39 million. Health Catalyst had a negative return on equity of 4.84% and a negative net margin of 74.24%. Research analysts forecast that Health Catalyst, Inc. will post -0.18 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on HCAT. Canaccord Genuity Group cut shares of Health Catalyst from a “buy” rating to a “hold” rating and reduced their price target for the company from $3.00 to $1.80 in a research report on Thursday, August 20th. Wells Fargo & Company decreased their price target on shares of Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a research note on Thursday, August 13th. Weiss Ratings restated a “sell (d-)” rating on shares of Health Catalyst in a report on Monday, October 26th. Finally, Citigroup cut their price objective on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating for the company in a research note on Tuesday, August 11th. Five research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $2.01.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Palogic Value Management L.P. bought a new position in shares of Health Catalyst during the second quarter valued at about $9,796,000. BlackRock Inc. purchased a new position in shares of Health Catalyst in the second quarter worth about $3,654,000. Hsbc Holdings PLC bought a new stake in shares of Health Catalyst in the 2nd quarter valued at about $809,000. Squarepoint Ops LLC lifted its stake in shares of Health Catalyst by 1,214.8% in the 2nd quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock valued at $796,000 after acquiring an additional 369,772 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in Health Catalyst during the 1st quarter worth approximately $276,000. 85.00% of the stock is owned by institutional investors.

Health Catalyst Company Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions are designed to help providers use clinical, operational, and financial data to support decision-making and improve care delivery. The company’s offerings include a data platform that brings together information from multiple sources, analytics applications for healthcare workflows, and professional services. These services can include implementation, data management, and support for organizations developing and applying analytics programs.